.With early stage 1 data today out in bush, metabolic condition attire Metsera is actually throwing ...
.Rivus Pharmaceuticals has unveiled the data behind its period 2 obesity succeed in heart failure pa...
.Bristol Myers Squibb is actually paying Excellent Medicine $110 thousand in advance to develop reag...
.Novartis has actually tattooed a bargain possibly worth much more than $1 billion with Flagship-fou...
.Lately debuted Metsera is actually unfolding some period 1 data for its own GLP-1 receptor agonist,...
.Amid the genetic medications branches race, Main Pioneering is introducing a brand new company to a...
.BioAge Labs is actually looking at around $180 million in first earnings from an IPO as well as an ...
.An effort through Merck & Co. to unlock the microsatellite stable (MSS) metastatic colon cancer ...
.Spain-based Asabys Allies has finalized a fund of 180 thousand europeans ($ 200 thousand), loan tha...
.BioAge Labs is producing just about $200 million by means of its Nasdaq IPO today, with the proceed...